Income Statement
Thermo Fisher Scientific Inc., selected items from income statement, long-term trends
US$ in millions
12 months ended: | Revenues | Operating income | Net income attributable to Thermo Fisher Scientific Inc. |
---|---|---|---|
Dec 31, 2023 | 42,857) | 6,859) | 5,995) |
Dec 31, 2022 | 44,915) | 8,393) | 6,950) |
Dec 31, 2021 | 39,211) | 10,028) | 7,725) |
Dec 31, 2020 | 32,218) | 7,794) | 6,375) |
Dec 31, 2019 | 25,542) | 4,594) | 3,696) |
Dec 31, 2018 | 24,358) | 3,783) | 2,938) |
Dec 31, 2017 | 20,918) | 2,968) | 2,225) |
Dec 31, 2016 | 18,274) | 2,449) | 2,022) |
Dec 31, 2015 | 16,965) | 2,336) | 1,975) |
Dec 31, 2014 | 16,890) | 2,503) | 1,894) |
Dec 31, 2013 | 13,090) | 1,610) | 1,273) |
Dec 31, 2012 | 12,510) | 1,482) | 1,178) |
Dec 31, 2011 | 11,726) | 1,245) | 1,330) |
Dec 31, 2010 | 10,789) | 1,265) | 1,036) |
Dec 31, 2009 | 10,110) | 1,049) | 850) |
Dec 31, 2008 | 10,498) | 1,229) | 994) |
Dec 31, 2007 | 9,746) | 974) | 761) |
Dec 31, 2006 | 3,792) | 242) | 169) |
Dec 31, 2005 | 2,633) | 263) | 223) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Assets
Current assets | Total assets | |
---|---|---|
Dec 31, 2023 | 24,589) | 98,726) |
Dec 31, 2022 | 25,229) | 97,154) |
Dec 31, 2021 | 20,113) | 95,123) |
Dec 31, 2020 | 21,957) | 69,052) |
Dec 31, 2019 | 11,893) | 58,381) |
Dec 31, 2018 | 10,625) | 56,232) |
Dec 31, 2017 | 9,421) | 56,669) |
Dec 31, 2016 | 7,021) | 45,908) |
Dec 31, 2015 | 5,741) | 40,889) |
Dec 31, 2014 | 6,540) | 42,852) |
Dec 31, 2013 | 9,881) | 31,863) |
Dec 31, 2012 | 4,835) | 27,445) |
Dec 31, 2011 | 4,822) | 26,834) |
Dec 31, 2010 | 4,135) | 21,349) |
Dec 31, 2009 | 4,531) | 21,625) |
Dec 31, 2008 | 4,346) | 21,090) |
Dec 31, 2007 | 3,665) | 21,207) |
Dec 31, 2006 | 3,660) | 21,262) |
Dec 31, 2005 | 1,354) | 4,252) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Thermo Fisher Scientific Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
Current liabilities | Total obligations | Total Thermo Fisher Scientific Inc. shareholders’ equity | |
---|---|---|---|
Dec 31, 2023 | 14,012) | 34,917) | 46,735) |
Dec 31, 2022 | 17,010) | 34,488) | 43,978) |
Dec 31, 2021 | 13,436) | 34,870) | 40,793) |
Dec 31, 2020 | 10,304) | 21,735) | 34,507) |
Dec 31, 2019 | 6,197) | 17,752) | 29,675) |
Dec 31, 2018 | 6,147) | 18,990) | 27,586) |
Dec 31, 2017 | 7,048) | 21,008) | 25,413) |
Dec 31, 2016 | 4,866) | 16,628) | 21,539) |
Dec 31, 2015 | 4,147) | 12,527) | 21,350) |
Dec 31, 2014 | 5,350) | 14,564) | 20,548) |
Dec 31, 2013 | 3,126) | 10,487) | 16,856) |
Dec 31, 2012 | 2,093) | 7,124) | 15,465) |
Dec 31, 2011 | 3,113) | 7,028) | 15,038) |
Dec 31, 2010 | 1,710) | 2,137) | 15,361) |
Dec 31, 2009 | 1,639) | 2,183) | 15,431) |
Dec 31, 2008 | 1,540) | 2,058) | 14,927) |
Dec 31, 2007 | 1,902) | 2,195) | 14,488) |
Dec 31, 2006 | 2,152) | 2,664) | 13,912) |
Dec 31, 2005 | 792) | 599) | 2,793) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Cash Flow Statement
Thermo Fisher Scientific Inc., selected items from cash flow statement, long-term trends
US$ in millions
12 months ended: | Net cash provided by operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
---|---|---|---|
Dec 31, 2023 | 8,406) | (5,142) | (3,622) |
Dec 31, 2022 | 9,154) | (2,159) | (2,810) |
Dec 31, 2021 | 9,312) | (21,932) | 6,581) |
Dec 31, 2020 | 8,289) | (1,510) | 959) |
Dec 31, 2019 | 4,973) | (1,487) | (3,118) |
Dec 31, 2018 | 4,543) | (1,253) | (2,237) |
Dec 31, 2017 | 4,006) | (7,729) | 3,854) |
Dec 31, 2016 | 3,158) | (5,532) | 2,861) |
Dec 31, 2015 | 2,826) | (1,087) | (2,491) |
Dec 31, 2014 | 2,624) | (11,783) | 4,796) |
Dec 31, 2013 | 2,016) | (263) | 3,310) |
Dec 31, 2012 | 2,068) | (1,385) | (918) |
Dec 31, 2011 | 1,678) | (5,902) | 3,551) |
Dec 31, 2010 | 1,499) | (863) | (1,295) |
Dec 31, 2009 | 1,660) | (830) | (558) |
Dec 31, 2008 | 1,422) | (458) | (228) |
Dec 31, 2007 | 1,485) | (617) | (929) |
Dec 31, 2006 | 407) | 279) | (260) |
Dec 31, 2005 | 273) | (819) | 391) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Per Share Data
12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
---|---|---|---|
Dec 31, 2023 | 15.52 | 15.45 | 1.40 |
Dec 31, 2022 | 17.75 | 17.63 | 1.20 |
Dec 31, 2021 | 19.62 | 19.46 | 1.04 |
Dec 31, 2020 | 16.09 | 15.96 | 0.88 |
Dec 31, 2019 | 9.24 | 9.17 | 0.76 |
Dec 31, 2018 | 7.31 | 7.24 | 0.68 |
Dec 31, 2017 | 5.64 | 5.59 | 0.60 |
Dec 31, 2016 | 5.12 | 5.09 | 0.60 |
Dec 31, 2015 | 4.96 | 4.92 | 0.60 |
Dec 31, 2014 | 4.76 | 4.71 | 0.60 |
Dec 31, 2013 | 3.53 | 3.48 | 0.60 |
Dec 31, 2012 | 3.24 | 3.21 | 0.54 |
Dec 31, 2011 | 3.49 | 3.46 | 0.00 |
Dec 31, 2010 | 2.57 | 2.53 | 0.00 |
Dec 31, 2009 | 2.06 | 2.01 | 0.00 |
Dec 31, 2008 | 2.38 | 2.29 | 0.00 |
Dec 31, 2007 | 1.81 | 1.72 | 0.00 |
Dec 31, 2006 | 0.86 | 0.84 | 0.00 |
Dec 31, 2005 | 1.38 | 1.36 | 0.00 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.